NovoCure Limited - Ordinary Shares (NVCR) stock analysis
NVCR · NovoCure Limited - Ordinary Shares
Latest recorded price: USD 11.30
Sector and industry: Healthcare · Medical Devices
Fiscal 2025 figures: revenue growth 6.8%, free cash flow margin -11.5%, ROIC -165.7%. The model flags 1 risk signal for this company (1 high severity).